Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Financings

Bausch + Lomb allocates $2.8B to refinance term loans

By The Northwire Desk — AI Analysis Dec 12, 2025 · 17:25 BLCO · 23.32 Bausch + Lomb Corp
BLCO · Price

Executive Summary

  • Bausch + Lomb Corp. has allocated a $2.8 billion tranche of new Term B loans to refinance its existing outstanding Term B loans maturing in 2028 and 2031.
  • The refinancing includes a maturity extension for the first incremental term loans, pushing the maturity date from September 29, 2028, to January 15, 2031.
  • The transaction is anticipated to close in the first quarter of 2026, subject to standard closing conditions.

Key Details

  • Transaction Amount: $2,802,125,000 allocated for new Term B loans (replacement term loans).
  • Use of Proceeds: To refinance all outstanding Term B loans due 2031 and all outstanding Term B loans due 2028.
  • Maturity Date: January 15, 2031 (same as the third amendment term loans; extends the first incremental term loans from September 29, 2028).
  • Interest Rate Margins:
    • 3.75% per annum for loans referencing term SOFR.
    • 2.75% per annum for loans referencing the alternate base rate.
  • Margin Reductions:
    • 0.50% per annum reduction for the third amendment term loans.
    • 0.25% per annum reduction for the first incremental term loans.
  • Closing Timeline: Anticipated to close in the first quarter of 2026.
  • Risk Factors: No assurances that the company will be able to complete the transactions on the described terms or at all.
Read the original news release →

More from Bausch + Lomb Corp

Jul 01, 2026 · 07:00

Dry Eye Survey Reinforces Premium Pricing Power, But Lacks Catalyst to Break Recent Consolidation

Other Jun 01, 2026 · 06:59

Bausch + Lomb Expands Dry Eye Portfolio with Preservative-Free Blink Launch; Execution on $7B Pipeline Continues Amid Margin Expansion

Financings May 19, 2026 · 07:00

Bausch + Lomb Executes H1 2026 Launch Plan Amidst Margin Expansion Push

Other May 07, 2026 · 07:00

Bausch + Lomb Expands Surgical Portfolio with European Bi-Blade+ Launch Amidst Guidance Raise

Other May 06, 2026 · 07:15

Bausch + Lomb Pipeline Webinar Confirms Long-Term Growth Narrative, But Near-Term Surgical Headwinds Persist Despite Q1 Guidance Raise

Other Apr 30, 2026 · 07:00

Bausch + Lomb Pipeline Validation Follows Q1 Guidance Raise Amidst Margin Expansion

Other